Close Menu

NEW YORK (360Dx) – Mologic and Fraunhofer today announced a collaboration to develop a rapid, point-of-care test for the diagnosis of bacterial urinary tract infections and any associated antibiotic susceptibility.

The test being developed would be used in a primary care setting. Fraunhofer was awarded £900,000 ($1.3 million) by SBRI Healthcare, a National Health Service England Initiative, in support of the project, the companies said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

May
10
Sponsored by
MeMed

Amid the COVID-19 pandemic, hospitals and intensive care units around the world have been overwhelmed by unprecedented levels of demand. 

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.